The race for antiviral drugs to beat COVID — and the next pandemic
Despite dire warnings, a stockpile of ready compounds to fight viral pandemics was sorely lacking. Can drug-makers finally do the right thing? By Elie Dolgin The year 2003 was an ominous one for emerging infectious diseases. A pair of deadly influenza strains had leapt from birds to humans in Hong Kong and the Netherlands. And […]
Continue Reading